Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)

por Dai, Yu-Hong, Yu, Xiong-Jie, Xu, Hui-Ting, Zhuang, Liang, Zhang, Ming-Sheng, Zou, Yan-Mei, Fu, Qiang, Qiu, Hong, Yuan, Xiang-Lin
Publicado 2022